Evolent Health (EVH) Net Cash Flow (2015 - 2026)

Evolent Health's Net Cash Flow history runs 12 years deep, the most recent figure standing at -$11.4 million for Q1 2026.

• In Q1 2026, Net Cash Flow fell 111.44% year-over-year to -$11.4 million; the TTM figure through Mar 2026 stood at -$108.0 million (down 342.51% YoY), while the FY2025 annual figure was $2.7 million, up 106.0% from the prior year.
• Net Cash Flow was -$11.4 million for Q1 2026 at Evolent Health, down from $37.9 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $99.3 million in Q1 2025 to a low of -$99.8 million in Q2 2025.
• Historically, Net Cash Flow has averaged -$10.8 million across 5 years, with a median of -$1.0 million in 2023.
• Biggest YoY gain for Net Cash Flow was 5063.93% in 2024; the steepest drop was 711.04% in 2024.
• A 5-year view of Net Cash Flow shows it stood at $20.4 million in 2022, then tumbled by 105.02% to -$1.0 million in 2023, then soared by 5063.93% to $50.8 million in 2024, then fell by 25.33% to $37.9 million in 2025, then plunged by 129.97% to -$11.4 million in 2026.
• The last three Net Cash Flow figures came in at -$11.4 million (Q1 2026), $37.9 million (Q4 2025), and -$34.8 million (Q3 2025), per Business Quant data.